Last edition
News about "Shreehas Tambe"
Biocon Biologics Secures FDA Approval for Kirsty
Biocon Biologics has announced that it has received FDA approval for KIRSTY (Insulin Aspart-xjhz), making it the first and only interchangeable biosimilar to NovoLog in the US, marking a major milestone in expanding affordable insulin options.
Shreehas Tambe | 16/07/2025 | By Mrinmoy Dey
Biocon Biologics Receives European Commission Nod for Denosumab Biosimilars to Improve Bone Health
Biocon Biologics has received European Commission approval for its Denosumab biosimilars, Vevzuo and Evfraxy, thereby expanding access to advanced treatments for bone-related conditions across the EU.
Shreehas Tambe | 03/07/2025 | By Mrinmoy Dey | 123
Biocon Biologics appoints Shreehas Tambe as MD and CEO
Tambe has shaped and grown the company's biosimilars business
Shreehas Tambe | 06/12/2022 | By Sudeep Soparkar | 543
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy